Back to square oneBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b2332 (Published 10 June 2009) Cite this as: BMJ 2009;338:b2332
- Stephen J Evans, professor of pharmacoepidemiology1
- 1London School of Hygiene and Tropical Medicine, London WC1E 7HT
It is tragic that we now have a respected body, the Medicines and Healthcare products Regulatory Agency (MHRA), granting a licence for a product for which there is not only no evidence of efficacy but good evidence against any …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial